Oragenics Inc. Stock
Pros and Cons of Oragenics Inc. in the next few years
Pros
?
B****
?
S********** s********
?
G***** c******* t* c**********
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Oragenics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Oragenics Inc. | - | - | - | - | - | - | - |
| Solasia Pharma KK | -4.460% | -6.548% | -2.484% | -40.530% | -18.653% | -57.568% | -86.106% |
| India Globalization Capital | 1.670% | -4.839% | -26.708% | -28.485% | -29.762% | -32.359% | -84.325% |
| Larimar Therapeutics Inc. | 1.190% | 6.623% | 8.784% | -48.889% | -13.441% | -6.395% | -83.088% |
Comments
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat
Oragenics, Inc. (NYSE: OGEN) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OGEN provided by MarketBeat